|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$79,630.32 |
2.35% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$79,455.80 |
2.34% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$79,061.20 |
2.33% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$78,259.65 |
2.31% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$76,011.02 |
2.24% |
| Steris Plc |
STE |
G8473T100 |
298 |
$75,525.12 |
2.23% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$75,497.40 |
2.22% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$75,067.08 |
2.21% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$75,074.08 |
2.21% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$74,802.56 |
2.20% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$74,340.49 |
2.19% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$73,371.52 |
2.16% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$73,015.77 |
2.15% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$73,135.44 |
2.15% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$72,237.86 |
2.13% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$72,162.09 |
2.13% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$71,977.50 |
2.12% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$71,619.29 |
2.11% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$71,351.08 |
2.10% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$70,968.13 |
2.09% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,614.17 |
2.08% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$70,707.63 |
2.08% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$70,620.42 |
2.08% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$70,112.88 |
2.07% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$68,854.50 |
2.03% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,845.68 |
2.00% |
| Waters Corporation |
WAT |
941848103 |
147 |
$67,943.40 |
2.00% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$67,618.98 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,558.56 |
1.99% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$67,097.81 |
1.98% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$66,895.72 |
1.97% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$66,423.39 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,411.42 |
1.96% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$66,167.40 |
1.95% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,022.10 |
1.95% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$65,163.30 |
1.92% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,878.75 |
1.91% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$64,834.00 |
1.91% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,319.52 |
1.89% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,154.00 |
1.89% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$63,543.77 |
1.87% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$62,799.80 |
1.85% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$61,961.10 |
1.83% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$61,856.40 |
1.82% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$61,576.45 |
1.81% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$61,024.86 |
1.80% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$59,360.59 |
1.75% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,437.79 |
1.66% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,547.99 |
1.31% |
| US Dollar |
$USD |
|
22,804 |
$22,803.98 |
0.67% |
| Japanese Yen |
$JPY |
|
237,600 |
$1,486.49 |
0.04% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|